The Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, announced Friday the number of anti-doping controls carried out during the 2015 Tour de France. In total, 656 controls were conducted during the three-week race.
“We strengthened our strategy of targeted controls thanks to the use of information provided by numerous sources and to the support of an intelligence coordinator,” said Dr. Francesca Rossi, director of the CADF. “The collaboration with the French Anti-Doping Agency (AFLD) was excellent, and the targeted control strategy was discussed daily, taking into account the performance of riders and other data.”
Among the 656 controls, 482 were blood tests and 174 urine tests. The blood tests were analyzed in relation to the biological passport and for specific anti-doping analyses.
AFLD’s president, Bruno Genevois added, “All samples collected on the 2015 Tour de France were analyzed in France, at the Châtenay-Malabry laboratory, which is accredited by the World Anti-Doping Agency (WADA), and which uses all the latest detection methods.”
The CADF’s Lausanne laboratory was used for the pre-competition mission as well as a support laboratory during the event. The UCI, CADF, and AFLD have agreed to keep the samples for potential retrospective analyses in the future. As for all grands tours, all the collected samples concerning the best five riders in the general classification will be kept for 10 years for potential retrospective analyses. This year’s top finishers were: Chris Froome, Nairo Quintana, Alejandro Valverde, Vincenzo Nibali, and Alberto Contador, in that order, from first to fifth.
Only one rider was expelled from the 2015 Tour de France for a failed doping control, Katusha’s Luca Paolini.